EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSCLAG00000004314
Gene Symbol: RXRA
2 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSCLAG00000013699
Gene Symbol: RXRB
3 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSCLAG00000007511
Gene Symbol: RXRG
3 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSCLAG00000013481
Gene Symbol: RPL10A
3 Cross references
226 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCLAG00000012453
Gene Symbol: RPL11
2 Cross references
214 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSCLAG00000003801
Gene Symbol: RPL13
3 Cross references
247 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCLAG00000016120
Gene Symbol: RPL14
2 Cross references
246 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSCLAG00000013452
Gene Symbol: RPL15
3 Cross references
142 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSCLAG00000013325
Gene Symbol: RPL18
2 Cross references
301 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCLAG00000010952
Gene Symbol: RPL18A
2 Cross references
201 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCLAG00000015873
Gene Symbol: RPL19
2 Cross references
243 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCLAG00000007350
Gene Symbol: RPL22
3 Cross references
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).